#rdprofile.htm###contactus.htm
Latest News
PRESS RELEASE
1. Themis Medicare has witnessed business turn around in the H1 of 2012–13 with sales turnover registering growth of 44% compared to H1 of 2011-12.
2. Formulation sales jumped by more than 100% .
3. Positive EBIDTA margin of 13% to sales as against –ve 26% last H1.
4. Net Profit & EPS was +ve, against –ve last H1.
5. Improvement in market recovery in view of disciplinary measures adopted last year have yielded positively bringing down market dues substantially.
Themis API's

We have been able to make a remarkable impression globally in our strengths to Supply the world class API's to regulated and non regulated markets. All our products are supported with EDMF's in CTD Format. We already have

More...
Welcome to THEMIS Medicare

These words sum up the efforts of the Themis Group, which integrates people, processes and potential towards the betterment of mankind.

The company was promoted by Mr. Shantibhai D. Patel, a pioneer in Indian Pharmaceuticals Business. Themis Medicare is a joint venture pharmaceutical company, with Gedeon Richter Ltd., Hungary. The company in over three decades has made its presence felt in manufacturing and marketing innovative pharmaceutical products. More... 
Research Formulations
 

                        Our Facilities

More... 

                 In House Magazine


“REACH is our In House Magazine!
The current issue is the ‘First’ of two issues that will be released in the financial year 2012/2013. Herein you will find an interesting array of company related and general articles. We hope you will enjoy reading through!”

Visitor No :- HTML Counter